An overactive IL‐17‐IL‐23 pathway can explain both the key inflammatory aspects of disease (including enthesitis) and the paradoxical feature of systemic bone loss coupled with pathological bone neogenesis.26 This evidence concerns the gene IL17A and enthesitis.